Increasing Prevalence of Osteoporosis to Augment the Vertebral Compression Fracture Devices Market Growth


Vertebral compression fracture (VCF) is one of the most common osteoporotic fractures, which leads to persistent pain, reduced standard of living, weight reduction, depression, kyphotic deformities, and even death. One of many major causes of VCF in elderly women is Osteoporosis. Moreover, metastatic spinal tumors, traumatic injuries, metastatic bone disease, and multiple myeloma may also result in VCFs. Fractures end up in pain, debilitation, and lack of quality of life.



Market Dynamics:

Increasing prevalence of osteoporosis (a bone disease) is expected to propel the growth of the Vertebral Compression Fracture Devices Market. As an example, according to the International Osteoporosis Foundation (IOF), one in five men and one in three women around the globe (aged 50 and over) suffer a fracture brought on by weak bones. Moreover, one in five die within the year following fracture.

Moreover, increasing demand for minimally invasive spine surgeries in conjunction with the advent of minimally invasive spine surgeries is expected to augment the growth of the vertebral compression fracture devices market. As an example, in June 2020, Spinal Elements launched minimally invasive portfolio for spine surgery.

Growing geriatric population is expected to provide lucrative growth opportunities for players in the market. As an example, according to the World Health Organization (WHO), the world's population aged 60 years and older is expected to total 2 billion by 2050. VCF occurs in around 20% of people more than 70 years of age.

North America is expected to witness significant growth in the vertebral compression fracture devices market due to the increasing prevalence of spine injuries in the region. As an example, according to the National Spinal Cord Injury Statistical Center, annually around 17,730 new spinal cord injuries occur in the United States.

Competitive Analysis:

Major players operating in the Vertebral Compression Fracture Devices Market are CareFusion Corporation, DFine, Inc., Globus Medical, Zimmer Biomet Holdings, Stryker Corporation, Orthovita, Inc., VEXIM SA, Osseon LLC, Depuy Synthes, and Alphatec Holdings, Inc.

In December 2020, The Centers for Medicare and Medicaid Services (CMS) announced the SpineJack implantable fracture reduction system qualified for the Transitional Pass-Through (TPT) payment within the 2021 Medicare Hospital Outpatient Prospective Payment System. The SpineJack System now becomes one of only 11 medical devices to receive TPT status since 2016.

In September 2020, IZI Medical Products (Owings Mills, Md.) received the CE mark for the Kiva vertebral compression fracture (VCF) treatment system.

In August 2020, IZI Medical Products announced the completion of its vertebral compression fracture (VCF) treatment line with the introduction of the Osteo-Site Balloon for balloon kyphoplasty procedures.


Comments

Popular posts from this blog

Cross Linked Polyethylene Market Growth Accelerated by Increasing demand from pipe and cables application

Soda Ash Is An Essential Component Of Water Treatment

It Is Incredibly Effective To Create A Cohesive Online And In-Store Experience Using Smart Beacons